NIPER Raebareli Signs MoU, CDA, and Technology Transfer Agreement with Lofty Laboratories

Academia-Industry Partnership to Promote Indigenous Technology Commercialization in Biotechnology Sector Posted On: 08 MAY 2026 3:20PM by PIB Delhi National Institute of Pharmaceutical Education and Research (NIPER), Raebareli has signed a Memorandum of Understanding (MoU), Confidential Disclosure Agreement (CDA) , and Technology Transfer Agreement with Lofty Laboratories, Hyderabad to foster multidirectional collaboration in research, innovation, and technology commercialization. This MoU marks a significant step towards strengthening academia-industry partnerships aimed at advancing pharmaceutical and biotechnology research . During the signing ceremony, both the organizations agreed to adopt an industry-ready technology developed at NIPER-Raebareli for further commercialization and development. The collaboration will also include joint participation in research and development activities in areas of mutual interest. Speaking during the occasion, the Director of NIPER-Raebareli, Prof. Shubhini A. Saraf, stated that the MoU and technology transfer agreement would enable both institutions to complement each other’s research programs in multiple ways, including collaborative participation in the activities of the Institute’s Center of Excellence on Novel Drug Delivery Systems (CoE-NDDS). Prof. Saraf also highlighted the importance of the technology developed in CoE and expressed hope that several more technologies from the Institute would be ready for transfer by the end of the year. Addressing the gathering, Prof. Nihar Ranjan, Head, CoE-NDDS explained that commercialization of the present technology would significantly reduce the cost of gel-staining agents, which are extensively used worldwide in biology-related research, particularly in studies involving genes, cancer, and other nucleic acid-related diseases. He added that indigenous production of such novel gel-staining agents would contribute substantially towards strengthening India’s pharmaceutical and biotechnology sectors. ***** PC/PM (Release ID: 2259032) Visitor Counter : 1226 Read this release in: Urdu , हिन्दी , Tamil Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals NIPER Raebareli Signs MoU, CDA, and Technology Transfer Agreement with Lofty Laboratories Academia-Industry Partnership to Promote Indigenous Technology Commercialization in Biotechnology Sector Posted On: 08 MAY 2026 3:20PM by PIB Delhi National Institute of Pharmaceutical Education and Research (NIPER), Raebareli has signed a Memorandum of Understanding (MoU), Confidential Disclosure Agreement (CDA) , and Technology Transfer Agreement with Lofty Laboratories, Hyderabad to foster multidirectional collaboration in research, innovation, and technology commercialization. This MoU marks a significant step towards strengthening academia-industry partnerships aimed at advancing pharmaceutical and biotechnology research . During the signing ceremony, both the organizations agreed to adopt an industry-ready technology developed at NIPER-Raebareli for further commercialization and development. The collaboration will also include joint participation in research and development activities in areas of mutual interest. Speaking during the occasion, the Director of NIPER-Raebareli, Prof. Shubhini A. Saraf, stated that the MoU and technology transfer agreement would enable both institutions to complement each other’s research programs in multiple ways, including collaborative participation in the activities of the Institute’s Center of Excellence on Novel Drug Delivery Systems (CoE-NDDS). Prof. Saraf also highlighted the importance of the technology developed in CoE and expressed hope that several more technologies from the Institute would be ready for transfer by the end of the year. Addressing the gathering, Prof. Nihar Ranjan, Head, CoE-NDDS explained that commercialization of the present technology would significantly reduce the cost of gel-staining agents, which are extensively used worldwide in biology-related research, particularly in studies involving genes, cancer, and other nucleic acid-related diseases. He added that indigenous production of such novel gel-staining agents would contribute substantially towards strengthening India’s pharmaceutical and biotechnology sectors. ***** PC/PM (Release ID: 2259032) Academia-Industry Partnership to Promote Indigenous Technology Commercialization in Biotechnology Sector" /> <span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px"><strong><img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image001CVLD.jpg" style="height:353px; width:606px" /></strong></span></span></p> <p style="margin-left:0cm; margin-right:0cm; text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">National Institute of Pharmaceutical Education and Research (NIPER), Raebareli has signed a <strong>Memorandum of Understanding (MoU),</strong> <strong>Confidential Disclosure Agreement (CDA)</strong>, and <strong>Technology Transfer Agreement</strong> with <strong>Lofty Laboratories, Hyderabad</strong> to foster multidirectional collaboration in research, innovation, and technology commercialization.</span></span></p> <p style="margin-left:0cm; margin-right:0cm; text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">This MoU marks a significant step towards <strong>strengthening academia-industry</strong> partnerships aimed at <strong>advancing pharmaceutical and biotechnology research</strong>. During the signing ceremony, both the organizations agreed to adopt an industry-ready technology developed at NIPER-Raebareli for further commercialization and development. The collaboration will also include joint participation in research and development activities in areas of mutual interest.</span></span></p> <p style="margin-left:0cm; margin-right:0cm; text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">Speaking during the occasion, the Director of NIPER-Raebareli, Prof. Shubhini A. Saraf, stated that the MoU and technology transfer agreement would enable both institutions to complement each other’s research programs in multiple ways, including collaborative participation in the activities of the <strong>Institute’s Center of Excellence on Novel Drug Delivery Systems</strong> (CoE-NDDS).</span></span></p> <p style="margin-left:0cm; margin-right:0cm; text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">Prof. Saraf also highlighted the importance of the technology developed in CoE and expressed hope that several more technologies from the Institute would be ready for transfer by the end of the year.</span></span></p> <p style="margin-left:0cm; margin-right:0cm; text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px">Addressing the gathering, Prof. Nihar Ranjan, Head, CoE-NDDS explained that commercialization of the present technology would significantly reduce the cost of gel-staining agents, which are extensively used worldwide in biology-related research, particularly in studies involving genes, cancer, and other nucleic acid-related diseases. He added that indigenous production of such novel gel-staining agents would contribute substantially towards strengthening India’s pharmaceutical and biotechnology sectors. </span></span></p> <p style="margin-left:0cm; margin-right:0cm; text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px"><strong>*****</strong></span></span></p> <p style="margin-left:0cm; margin-right:0cm"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16px"><strong>PC/PM</strong></span></span></p> " /> var mPlayer = document.getElementById("background_music"); var mPlayAction = document.getElementById("playbutton"); var isPlaying = false; function playAudio() { mPlayer.play(); isPlaying = true; document.getElementById('stopA').style.display = "block"; document.getElementById('playA').style.display = "none"; } function pauseAudio() { mPlayer.pause(); isPlaying = false; document.getElementById('playA').style.display = "block"; document.getElementById('stopA').style.display = "none"; } //function HandleAudio() { // if (isPlaying == true) { // //Playing already Pause it // pauseAudio(); // } else { // //Play the music // playAudio(); // } //} var synth = window.speechSynthesis; function CleanHtml(html) { html = html.replace(/ /gi, ''); return html; } function stripHtml(html) { let tmp = document.createElement("DIV"); tmp.innerHTML = CleanHtml(html); return tmp.textContent || tmp.innerText || ""; } $(document).ready(function () { //for responsive tables $("table").each(function () { if (!$(this).closest(".table-responsive").length) { $(this).wrap(" "); } }); var width = $(window).width(); if (width $(document).ready(function () { var width = $(window).width(); if (width @media print { .sticky-social, .sticky-social_mb, .pull-right, #printPDF { display: none !important; } } .f_vl { padding-right: 30px; font-size: 17px; cursor: pointer; } .log_oo { // width: 20%; display: flex; justify-content: space-between; } .log_oo img { width: 150px; /*width: 100%; height: auto;*/ } .sticky-social_mb { position: fixed; bottom: 0px; padding: 0px; margin: 0px; width: 100%; } .social_mb { list-style: none; display: flex; width: 100%; margin-bottom: -8px; } .social_mb a { padding: 8px 0px; font-size: 30px; transition: all 0.8s ease-in-out; width: 20% !important; text-align: center; } .section1 { position: relative; padding: 10px 0px; width: 100%; } .sticky-social { position: fixed; top: 20px; left: 0px; padding: 0px; margin: 0px; } .social { list-style: none; } .social a li { padding: 8px 12px; font-size: 25px; transition: all 0.8s ease-in-out; } .social a li:hover { margin-right: -30px; box-shadow: 2px 5px 10px grey; } .social a li:hover .fa { margin-left: 20px; } .fb_b { /* background-color: rgb(59, 89, 152);*/ background-color: rgba(65,103,178,255); } .twitter_r { /* background-color: rgb(29, 161, 242);*/ background-color: #000000; } .whatsapp_r { /* background-color: rgb(77, 194, 71);*/ background-color: rgba(13,191,67,255); } .fa-envelope_r { /* background-color: rgb(219, 68, 55);*/ background-color: #e2123d; } .fa-linkedin_r { background-color: rgb(0, 119, 181); } @media only screen and (max-device-width: 767px) { p span img { max-width: 90% !important; height: auto !important; } p img { max-width: 90% !important; height: auto !important; } h2 { font-size: 20px !important; font-weight: 600 !important; } h3 { font-size: 18px !important; font-weight: 600 !important; } } /* === Film Roll Badge Styling(IFFI2025 countdown) === */ .film-roll-badge { position: absolute; top:82%; right: 20px; width: 230px; height: 70px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 18px, #6e2b8b 18px, #6e2b8b 36px ); border-top: 8px solid #9a2375; border-bottom: 8px solid #9a2375; border-radius: 8px; overflow: hidden; box-shadow: 0 4px 12px rgba(0, 0, 0, 0.4); animation: moveFilm 8s linear infinite; z-index: 10; } /* film sprocket holes */ .film-roll-badge::before, .film-roll-badge::after { content: ""; position: absolute; width: 100%; height: 10px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 10px, #fff 10px, #fff 20px ); left: 0; z-index: 2; } .film-roll-badge::before { top: -4px; } .film-roll-badge::after { bottom: -4px; } .film-roll-inner { position: relative; height: 100%; display: flex; align-items: center; justify-content: center; animation: flicker 2s infinite ease-in-out; } .countdown-text { font-size: 1.3rem; font-weight: 700; color: #fff; text-shadow: 0 0 6px rgba(255, 255, 255, 0.4), 0 0 10px #000; white-space: nowrap; } /* === Animations === */ @keyframes moveFilm { 0% { background-position: 0 0; } 100% { background-position: 120px 0; } } @keyframes flicker { 0%, 100% { opacity: 1; } 50% { opacity: 0.9; } 25% { opacity: 0.95; } 75% { opacity: 0.85; } } /* === Responsive Adjustments === */ @media (max-width: 1500px) { .film-roll-badge { top: 68%; right: 18px; /* width: 220px; */ height: 65px; font-size: 0.85rem; } .press-section { margin-top: 35px; } } @media (max-width: 992px) { .film-roll-badge { top: 52%; right: 10px; width: 200px; height: 60px; } } @media (max-width: 768px) { .film-roll-badge { top: 56%; right: 10px; width: 124px; height: 55px; } .countdown-text { font-size: 0.9rem; } } @media (max-width: 576px) { .film-roll-badge { top: 59%; right: 5px; /* width: 160px; */ height: 50px; } .countdown-text { font-size: 0.85rem; } } const festivalStart = new Date("2025-11-20T00:00:00").getTime(); const festivalEnd = new Date("2025-11-28T23:59:59").getTime(); const countdownElement = document.getElementById("countdown"); const interval = setInterval(() => { const now = new Date().getTime(); // BEFORE FESTIVAL — show days + hours left if (now = festivalStart && now el.style.width = "350px"); clearInterval(interval); } }, 1000); //